Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults.

Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults.

OBJECTIVES: Co-administration of artemether/lumefantrine with antiretroviral therapy has potential for pharmacokinetic drug interactions. We investigated drug-drug interactions between artemether/lumefantrine and efavirenz or nevirapine. METHODS: We performed a cross-over study in which HIV-infected...

Full description

Bibliographic Details
Main Authors:	Byakika-Kibwika, P, Lamorde, M, Mayito, J, Nabukeera, L, Namakula, R, Mayanja-Kizza, H, Katabira, E, Ntale, M, Pakker, N, Ryan, M, Hanpithakpong, W, Tarning, J, Lindegardh, N, de Vries, P, Khoo, S, Back, D, Merry, C
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults.
by: Byakika-Kibwika, P, et al.
Published: (2012)

Pharmacokinetics and pharmacodynamics of intravenous artesunate during severe malaria treatment in Ugandan adults.
by: Byakika-Kibwika, P, et al.
Published: (2012)

Artemether-lumefantrine coadministration with antiretrovirals; population pharmacokinetics and dosing implications.
by: Hoglund, R, et al.
Published: (2014)

Drug interactions between dolutegravir and artemether-lumefantrine or artesunate-amodiaquine
by: Walimbwa, S, et al.
Published: (2018)

Impact of efavirenz, ritonavir-boosted lopinavir and nevirapine based antiretroviral regimens on the pharmacokinetics of lumefantrine and safety of artemether-lumefantrine in falciparum-negative HIV-infected Malawian adults stabilized on antiretroviral therapy
by: Banda, CG, et al.
Published: (2018)

Population pharmacokinetics and pharmacodynamics of lumefantrine in young Ugandan children treated with artemether-lumefantrine for uncomplicated malaria
by: Tchaparian, E, et al.
Published: (2016)

Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine.
by: Ali, S, et al.
Published: (2010)

Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine
by: Byakika-Kibwika, P, et al.
Published: (2019)

Differential impact of nevirapine on artemether-lumefantrine pharmacokinetics in individuals stratified by CYP2B6 c.516G>T genotypes
by: Abdullahi, ST, et al.
Published: (2020)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
by: Tarning, J, et al.
Published: (2009)

Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers.
by: German, P, et al.
Published: (2009)

Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine
by: White, N, et al.
Published: (1999)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
by: Mcgready, R, et al.
Published: (2006)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
by: McGready, R, et al.
Published: (2009)

Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda.
by: Mwesigwa, J, et al.
Published: (2010)

Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria
by: Tarning, J, et al.
Published: (2022)

Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
by: White, N, et al.
Published: (1999)

Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia.
by: Denis, M, et al.
Published: (2006)

Severe acute malnutrition results in lower lumefantrine exposure in children treated with artemether‐lumefantrine for uncomplicated malaria
by: Chotsiri, P, et al.
Published: (2019)

Virologic response to first-line efavirenz- or nevirapine-based antiretroviral therapy in HIV-infected African children
by: Kekitiinwa, A, et al.
Published: (2017)

No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine.
by: van Vugt, M, et al.
Published: (1999)

Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.
by: van Vugt, M, et al.
Published: (2000)

Virologic response to first-line efavirenz- or nevirapine-based anti-retroviral therapy in HIV-infected African children
by: Kekitiinwa, A, et al.
Published: (2017)

Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
by: Peto, TJ, et al.
Published: (2022)

Efficacy and safety of artemether-lumefantrine as treatment for Plasmodium falciparum uncomplicated malaria in adult patients on efavirenz-based antiretroviral therapy in Zambia: an open label non-randomized interventional trial.
by: Banda, C, et al.
Published: (2019)

Artemether-lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania.
by: Färnert, A, et al.
Published: (2012)

DRUG-DRUG INTERACTIONS BETWEEN ARTEMETHER/LUMEFANTRINE AND LOPINAVIR/RITONAVIR IN HIV NEGATIVE HEALTHY VOLUNTEERS
by: German, P, et al.
Published: (2008)

Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine in combination treatment of uncomplicated falciparum malaria in pediatric patients
by: Hietala, S, et al.
Published: (2009)

Antimalarial resistance unlikely to explain U.K. artemether-lumefantrine failures
by: van der Pluijm, R, et al.
Published: (2017)

Genomic characterization of recrudescent plasmodium malariae after treatment with artemether/lumefantrine
by: Rutledge, G, et al.
Published: (2017)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia
by: Sipilanyambe, N, et al.
Published: (2008)

A case-control auditory evaluation of patients treated with artemether-lumefantrine.
by: Hutagalung, R, et al.
Published: (2006)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda.
by: Zurovac, D, et al.
Published: (2008)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda
by: Zurovac, D, et al.
Published: (2008)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia.
by: Sipilanyambe, N, et al.
Published: (2008)

Population pharmacokinetics of artemether, dihydroartemisinin and lumefantrine in Rwandese pregnant women treated for uncomplicated Plasmodium falciparum malaria
by: Das, J, et al.
Published: (2018)

Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.
by: Tarning, J, et al.
Published: (2013)

Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania.
by: Hietala, S, et al.
Published: (2010)

An individual participant data population pharmacokinetic meta-analysis of drug-drug interactions between lumefantrine and commonly used antiretroviral treatment
by: Francis, J, et al.
Published: (2020)

Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine or efavirenz in Uganda: a prospective non-randomized study
by: Mwesigire, D, et al.
Published: (2015)